<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="189280">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629421</url>
  </required_header>
  <id_info>
    <org_study_id>KMUH-IRB-960012</org_study_id>
    <nct_id>NCT00629421</nct_id>
  </id_info>
  <brief_title>Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study</brief_title>
  <official_title>Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although serum alpha-fetoprotein level and abdominal sonography are the main methods to
      screening hepatocellular carcinoma (HCC) in cirrhotic patients, the adequate time and
      methods used are not completely well-defined. This study aims to assess the better timing
      and methods for prospectively screening HCC in patients with cirrhosis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Well-diagnosed consecutive patients with cirrhosis were enrolled through a designed
      questionnaire to obtain basic information about gender, age, etiology of cirrhosis,
      conventional liver function tests, serum AFP level, education level, substance use including
      smoking, alcohol drinking, betel quid chewing, history of familial HCC, etc. Then the
      patients was followed by periodic abdominal sonography examination and determination of AFP
      and liver function. If AFP elevated or liver nodule appears, effort to diagnose HCC will be
      performed.If HCC was performed, the survival will be followed-up.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2001</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>development of hepatocellular carcinoma</measure>
    <time_frame>during observation</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Well-dignosed patients with cirrhosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Image diagnosis or biochemical diagnosis or presence of portal hypertension

        Exclusion Criteria:

          -  Presence of hepatocellular carcinoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung-Fa Tsai, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaohsiung Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jung-Fa Tsai, M.D., Ph.D.</last_name>
    <phone>886-7-3121101</phone>
    <phone_ext>7475</phone_ext>
    <email>jftsai@cc.kmu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jung-Fa Tsai, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 17, 2013</lastchanged_date>
  <firstreceived_date>February 26, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaohsiung Medical University Chung-Ho Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Jung-Fa,Tsai</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
